Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04666779
Other study ID # CohortChiroCOVID19
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 18, 2020
Est. completion date September 15, 2021

Study information

Verified date September 2021
Source Real Centro Universitario Maria Cristina
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is a prospective comparative cohort trial taking place during the first year of the Coronavirus-19 (COVID-19) pandemic in Spain. Chiropractic patients throughout Spain were invited to participate independently of the care received, including patients who had stopped visiting their chiropractors since the pandemic hit. The main exposure variable is the access to chiropractic care services, and the degree of this exposure during the months following initial lockdown phase in Spain. Participants will fill an online questionnaire with self-reported outcome-measures.


Recruitment information / eligibility

Status Completed
Enrollment 399
Est. completion date September 15, 2021
Est. primary completion date February 21, 2021
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - chiropractic patients with pain, active when lockdown was declared, over the age of 16 Exclusion Criteria: - new patients in the clinic after the pandemic hit

Study Design


Related Conditions & MeSH terms

  • Access to Chiropractic Care Services
  • COVID-19

Intervention

Other:
Chiropractic care
Care provided by chiropractors, based on manual therapy, exercise prescription and patient advice/education/reassurance

Locations

Country Name City State
Spain Real Centro Universitario María Cristina San Lorenzo De El Escorial Madrid

Sponsors (4)

Lead Sponsor Collaborator
Real Centro Universitario Maria Cristina Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Université du Québec à Trois-Rivières, University of Birmingham

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity Numerical Rating Scale (0-10, 0=no pain, 10=maximum pain) 6 months
Primary Pain duration Duration of pain symptoms, PREVIOUS to the study, measured in months (up to 3 months, more than 3 months) 6 months
Primary Pain frequency Ranges: Constant, every day, every week, occasionally 6 months
Primary Pain perceived improvement Categories: New pain, worsened, no change, improv, gone 6 months
Primary Pain interference From the Brief Pain Inventory (7 items, 0-10: 0= minimal score, 70=maximal score) 6 months
Primary Pain Catastrophizing Scale Validated questionnaire (short version 4 items, 1-4: 4= minimal score, 16=maximal score) 6 months
Primary Tampa Scale Kinesiophobia Validated questionnaire (short version 11 items, 0-3: 0=minimal score, 33=maximal score) 6 months
Secondary General Anxiety Disorder scale Validated questionnaire (7 items , 1-3: 1= minimal score, 21=maximal score) 6 months
Secondary Fear of Illness and Virus Evaluation Questionnaire (12 items, 1-4: 1=minimal score, 48=maximal score) 6 months